“Efficacy and Safety of Roflumilast Cream 0.15% in Adults and Children Aged ≥6 Years With Mild to Moderate Atopic Dermatitis in Two Phase 3 Trials (INTEGUMENT-1 and INTEGUMENT-2)”, J of Skin, vol. 7, no. 4, p. s220, Jul. 2023, doi: 10.25251/skin.7.supp.220.